Get the Stockscreener App
418.61
0.55%
2.27
Pre-market:
420.00
1.39
+0.33%
Idexx Laboratories Inc stock is traded at $418.61, with a volume of 640.75K.
It is up +0.55% in the last 24 hours and down -8.55% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$416.34
Open:
$413.38
24h Volume:
640.75K
Relative Volume:
1.25
Market Cap:
$33.80B
Revenue:
$3.84B
Net Income/Loss:
$866.24M
P/E Ratio:
42.72
EPS:
9.8
Net Cash Flow:
$792.60M
1W Performance:
-2.61%
1M Performance:
-8.55%
6M Performance:
-21.03%
1Y Performance:
-11.49%
1-Day Range:
$410.29
$419.41
1-Week Range:
$408.95
$430.11
52-Week Range:
$404.74
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| IDXX | 418.61 | 33.80B | 3.84B | 866.24M | 792.60M | 9.80 |
| TMO | 512.84 | 195.55B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 233.10 | 166.92B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 128.57 | 36.94B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 194.38 | 35.03B | 15.32B | 1.41B | 1.96B | 5.95 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Pathstone Holdings LLC - MarketBeat
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
B. Metzler seel. Sohn & Co. Holding AG Makes New $4.67 Million Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Quest Partners LLC - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by LGT Capital Partners LTD. - MarketBeat
At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List? - Simply Wall St
Thrivent Financial for Lutherans Acquires 65,050 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Natixis Advisors LLC Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Veterinary Point-of-Care Diagnostics Market 2024-2031 | - openPR
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by Mizuho Securities USA LLC - MarketBeat
CIBC Asset Management Inc Acquires 1,338 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Comgest Global Investors S.A.S. Buys 12,353 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
ING Groep NV Trims Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Sees Unusually High Options Volume (NASDAQ:IDXX) - MarketBeat
First Week of July 2025 Options Trading For Idexx Laboratories (IDXX) - Nasdaq
IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 10% CAGR over the last five years - Yahoo Finance
KBC Group NV Has $51 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Victory Capital Management Inc. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Acquires 3,233 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Entropy Technologies LP Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Jonathan W. Ayers Resigns from IDEXX Laboratories (IDXX) Board o - GuruFocus.com
Idexx Laboratories Announces CEO Jonathan Ayers’ Resignation - TipRanks
ACVIM and IDEXX Partner to Provide Free Educational Offerings for ACVIM Residents - Business Wire
Crystal Rock Capital Management Purchases 4,265 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
2,720 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by Versor Investments LP - MarketBeat
IDEXX Labs: Will Its Enhanced Diagnostic Capabilities & Innovation Bring A Shift In The Competitive Dynamics?Major Drivers - Smartkarma
IDEXX Laboratories Q3: Weak End-Market Demand Continues - Seeking Alpha
Jensen Investment Management Inc. Raises Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by TimesSquare Capital Management LLC - MarketBeat
Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - Yahoo Finance
Villere ST Denis J & Co. LLC Lowers Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Friday, still underperforms market - MarketWatch
Fiera Capital Corp Has $63.52 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Principal Financial Group Inc. Decreases Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. Updates Earnings Guidance for the Full Year of 2024 - Marketscreener.com
Is IDEXX Laboratories (IDXX) The Best Pet Stock To Invest In According To Analysts? - Insider Monkey
IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market - MarketWatch
IDEXX Laboratories, Inc. Updates Earnings for the Full Year 2024 - Marketscreener.com
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects? - Yahoo Finance
National Pension Service Raises Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Van ECK Associates Corp Grows Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Is It Time to Buy October's Worst-Performing Nasdaq Stocks? - The Motley Fool
IDEXX Laboratories' SWOT analysis: veterinary diagnostics leader faces market shifts - Investing.com Australia
IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market - MarketWatch
Vanguard Group Inc's Strategic Acquisition of IDEXX Laboratories Shares - GuruFocus.com
IDEXX Laboratories (NASDAQ:IDXX) Given "Neutral" Rating at Piper Sandler - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $481.00 at Barclays - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.59%
2.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):